1. Home
  2. FVRR vs AKBA Comparison

FVRR vs AKBA Comparison

Compare FVRR & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FVRR
  • AKBA
  • Stock Information
  • Founded
  • FVRR 2010
  • AKBA 2007
  • Country
  • FVRR Israel
  • AKBA United States
  • Employees
  • FVRR N/A
  • AKBA N/A
  • Industry
  • FVRR Business Services
  • AKBA Biotechnology: Pharmaceutical Preparations
  • Sector
  • FVRR Consumer Discretionary
  • AKBA Health Care
  • Exchange
  • FVRR Nasdaq
  • AKBA Nasdaq
  • Market Cap
  • FVRR 1.0B
  • AKBA 958.6M
  • IPO Year
  • FVRR 2019
  • AKBA 2014
  • Fundamental
  • Price
  • FVRR $30.02
  • AKBA $3.55
  • Analyst Decision
  • FVRR Buy
  • AKBA Strong Buy
  • Analyst Count
  • FVRR 12
  • AKBA 5
  • Target Price
  • FVRR $35.00
  • AKBA $6.90
  • AVG Volume (30 Days)
  • FVRR 473.5K
  • AKBA 6.2M
  • Earning Date
  • FVRR 07-30-2025
  • AKBA 08-07-2025
  • Dividend Yield
  • FVRR N/A
  • AKBA N/A
  • EPS Growth
  • FVRR 127.71
  • AKBA N/A
  • EPS
  • FVRR 0.49
  • AKBA N/A
  • Revenue
  • FVRR $405,141,000.00
  • AKBA $184,909,000.00
  • Revenue This Year
  • FVRR $13.12
  • AKBA $26.88
  • Revenue Next Year
  • FVRR $8.65
  • AKBA $44.34
  • P/E Ratio
  • FVRR $60.32
  • AKBA N/A
  • Revenue Growth
  • FVRR 10.41
  • AKBA N/A
  • 52 Week Low
  • FVRR $20.78
  • AKBA $0.91
  • 52 Week High
  • FVRR $36.11
  • AKBA $4.08
  • Technical
  • Relative Strength Index (RSI)
  • FVRR 45.04
  • AKBA 55.38
  • Support Level
  • FVRR $28.63
  • AKBA $3.60
  • Resistance Level
  • FVRR $29.74
  • AKBA $3.76
  • Average True Range (ATR)
  • FVRR 0.87
  • AKBA 0.18
  • MACD
  • FVRR -0.21
  • AKBA -0.05
  • Stochastic Oscillator
  • FVRR 25.28
  • AKBA 15.62

About FVRR Fiverr International Ltd. no par value

Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Wiring and Translation, and Video and Animation among others.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients, HIF-PH inhibitors in preclinical development.

Share on Social Networks: